Veraxa Biotech Holding AG (VRXA) Short-term Investments (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Short-term Investments for 2 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments rose 693.06% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 693.06% YoY), and the FY2025 full-year result was $1.4 million, up 693.06% from the prior year.
• Short-term Investments improved to $1.4 million in Q4 2025 per VRXA's latest filing, from $175344.6 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.4 million in Q4 2025 to a low of $175344.6 in Q4 2024.